Although PDGF appears to be a poor therapeutic target, PDGFRalpha is particularly attractive because it can be activated by a much larger spectrum of vitreal growth factors than previously appreciated.
No takes yet. Share an insight, caveat, or question.
Lei et al. (2009) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: